Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 0.55% | 89.14 | 1.3% | $797.85m | |
| AMGN | Amgen Inc. | 1.08% | 187.50 | 1.2% | $644.97m | |
| GILD | Gilead Sciences, Inc. | 0.29% | 65.74 | 0.9% | $476.37m | |
| BIIB | Biogen Inc. | 1.30% | 325.33 | 1.3% | $432.61m | |
| ILMN | Illumina, Inc. | 1.41% | 301.06 | 3.5% | $311.78m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.93% | 422.52 | 2.6% | $280.54m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.48% | 185.76 | 1.9% | $246.69m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.71% | 129.73 | 2.0% | $214.36m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.52% | 139.98 | 15.4% | $157.00m | |
| A | Agilent Technologies, Inc. | 0.67% | 78.41 | 1.6% | $155.05m | |
| EXAS | Exact Sciences Corporation | 10.52% | 92.04 | 25.3% | $150.72m | |
| INCY | Incyte Corporation | 1.82% | 84.85 | 2.5% | $112.02m | |
| ARRY | Array BioPharma Inc. | 2.33% | 23.24 | 8.2% | $111.41m | |
| NBIX | Neurocrine Biosciences, Inc. | 2.07% | 78.91 | 5.1% | $80.47m | |
| EXEL | Exelixis, Inc. | 1.41% | 21.52 | 6.4% | $79.74m |
Company Profile
Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY.